The safety and efficacy of this agent(s), or use in this setting, has not been established or is subject to confirmation. For an agent(s) whose safety and efficacy has not been established or confirmed, future regulatory approval or commercial availability is not guaranteed.
Clinical Trial Selector
Geo Regions
BackMaplirpacept (SIRPα-IgG4 Fusion Protein)
Maplirpacept (TTI-622/PF-07901801) is an investigational compound. Its safety and efficacy have not been established.
